🟢 Harrow Health Inc is trading 5.5% up as new investor presentation highlights growth outlook

Harrow Health Inc is trading at $35.15 (5.5% up) after the company provided a fresh business outlook to investors.

• On June 3, the company released a new June 2026 corporate presentation and presented at the William Blair Growth Stock Conference.
• The updates likely reiterated the company's confidence in its full-year guidance and the strong underlying prescription growth for its key products, which was also a focus during its Q1 earnings report in May.
• This appears to have reinforced investor sentiment, continuing a rebound from the stock's decline following the Q1 earnings miss announced on May 11.